Biljana Stupar

Biljana Stupar has a strong background in the pharmaceutical industry. Biljana is currently the Head of Product Development at Wörwag Pharma GmbH & Co. KG since March 2020. Prior to that, they were self-employed as a Manager from October 2018 to March 2020. From 2014 to 2018, Biljana was the Director of R&D at HEMOFARM AD, a member of the STADA group. Before that, they served as the Deputy Director from 2011 to 2014 and the Head of Development Department from 1994 to 2011. Earlier in their career, they worked as a Development Specialist at Hemofarm A.D. from 1992 to 1994.

Biljana Stupar obtained their BSc in pharmacy from the University of Sarajevo. Further, they pursued a degree in Pharmaceutical technology from the University of Belgrade - Faculty of Pharmacy, earning a Spec. Pharm. tech. degree. Later, they enrolled in The University of Sheffield and completed their Master of Business Administration (MBA) degree. The field of study for their BSc in pharmacy and MBA degree is not specified in the provided information.